提亚索利丁的分子混合物:弥合氧化调节和癌症治疗的桥梁
Nourah A Al Zahrani1, Manal A Alshabibi2, Abrar A Bakr2
1Department of Chemistry, College of Science, University of Jeddah, Jeddah 23218, Saudi Arabia.
International journal of molecular sciences
|July 12, 2025
概括
合成了新型的 thiazolidinone 衍生物,并对其生物活性进行了评估. TZD-7显示有选择性的抗癌作用,而TZD-5显示强烈的抗氧化活性,使它们成为治疗开发的有希望的候选人.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 异环化合物,特别是 thiazolidinones,对于开发新型治疗剂至关重要.
- 持续需要新的候选药物来对抗癌症,感染和与氧化压力相关的疾病.
研究的目的:
- 合成和结构性表征新的 thiazolidinone 衍生物.
- 评估合成的 thiazolidinone 衍生物的抗氧化和细胞毒性活动.
- 确定选择性抗癌和抗氧化剂疗法的有前途的候选者.
主要方法:
- 使用IR,1H NMR和13C NMR光谱学合成和对 thiazolidinone 衍生物的结构性表征.
- 通过DPPH测定评估抗氧化活性.
- 使用MTS测定对正常 (HFF-1) 和癌症 (HepG2,A549) 细胞系的细胞毒性评估.
主要成果:
- TZD-5表现出强烈的抗氧化活性 (IC50 = 24.4 μg/mL),与 Askorbic 酸相当.
- TZD-1和TZD-6对癌症和正常细胞系均表现出显著的细胞毒性,表明选择性有限.
- TZD-7对HepG2和A549癌细胞表现出强烈的选择性细胞毒性,对正常的HFF-1细胞的影响最小.
- TZD-5表现出中度选择性,对HepG2细胞的疗效更高.
结论:
- 提阿佐利丁衍生物TZD-5和TZD-7具有显著的生物活性.
- TZD-5是一种强大的抗氧化剂,归因于其甲基组.
- 作为选择性抗癌剂,TZD-7具有良好的安全性.
- 这些衍生品需要进一步研究在瘤学和氧化应激障碍中的治疗应用.
更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
306
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
306
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.1K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.1K


